What compensation terms are offered to Apellis common stock purchasers?

Question

Accepted Answer

Compensation Terms for Apellis Common Stock Purchasers

Purchasers of Apellis common stock between January 28, 2021, and July 28, 2023, may be eligible for compensation without incurring out-of-pocket expenses, operating under a contingency fee arrangement. This structure means legal fees are contingent upon a successful recovery, ensuring that investors do not pay for legal services unless the case results in a settlement or judgment. The Rosen Law Firm, which is handling the class action, emphasizes that investors can seek this compensation without upfront costs.
Contingency Fee Arrangement

The class action framework allows for a contingency fee arrangement, a common practice in securities litigation. Under this model, the law firm's fees are calculated as a percentage of the total recovery obtained for the class. This arrangement is designed to make legal representation accessible to investors who may not have the financial resources to pursue litigation otherwise.
No Out-of-Pocket Fees

A significant aspect of the offered terms is the absence of out-of-pocket fees for the investors involved. This means that individuals participating in the class action will not be required to pay legal costs, filing fees, or other expenses directly from their own funds. The responsibility for these costs is borne by the law firm, to be recouped only if and when compensation is secured for the class.
Potential for Recovery

The lawsuit alleges that Apellis Pharmaceuticals, Inc. made false and/or misleading statements and failed to disclose critical information regarding the design of clinical trials for its drug SYFOVRE. Specifically, it is claimed that the trial design was insufficient to identify incidents of retinal vasculitis, creating unknown risks for SYFOVRE's commercial adoption. If these allegations are proven, investors who purchased Apellis common stock during the specified period may be entitled to damages.

Reading history

Hide →

This history is cleared when the page is closed.

What compensation terms are offered to Apellis common stock purchasers?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends